Predictions
Copper Mountain Mining
Start price
Target price
Perf. (%)
€1.40
17.10.22
17.10.22
-
17.10.23
17.10.23
23.83%
18.10.23
18.10.23
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Future proof or reliable business model
Revenue growth >5% per year expected
ITM Power plc
Start price
Target price
Perf. (%)
€1.08
17.10.22
17.10.22
€2.00
17.10.23
17.10.23
-21.91%
18.10.23
18.10.23
Medium risks for its business
Innovative
Sustainability is important
Significant cyclical dependencies
Proton Motor Power Systems plc
Start price
Target price
Perf. (%)
€0.12
17.10.22
17.10.22
€0.000
17.10.23
17.10.23
3.69%
17.10.22
17.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Mag Silver Corp.
Start price
Target price
Perf. (%)
€12.89
17.10.22
17.10.22
-
17.10.23
17.10.23
-2.21%
30.01.23
30.01.23
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Jaguar Mining Inc.
Start price
Target price
Perf. (%)
€2.05
17.10.22
17.10.22
-
17.10.23
17.10.23
-4.87%
23.01.23
23.01.23
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Aya Gold & Silver Inc.
Start price
Target price
Perf. (%)
€5.99
17.10.22
17.10.22
-
17.10.23
17.10.23
-1.60%
18.01.23
18.01.23
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Relmada Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.70
17.10.22
17.10.22
-
17.10.23
17.10.23
-2.99%
29.10.22
29.10.22
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
AMTD IDEA Group ADR
Start price
Target price
Perf. (%)
€2.08
17.10.22
17.10.22
-
17.10.23
17.10.23
0.96%
29.10.22
29.10.22
Could be worthwhile Investment >10% per year
Very capable Management
Few uniques
Cronos Group Inc.
Start price
Target price
Perf. (%)
€2.85
17.10.22
17.10.22
-
17.10.23
17.10.23
-3.05%
09.11.22
09.11.22
Could be very worthwhile Investment >20% year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.44
17.10.22
17.10.22
-
17.10.23
17.10.23
-7.41%
22.12.22
22.12.22
Risky Investment
Tilray Inc
Start price
Target price
Perf. (%)
€3.21
17.10.22
17.10.22
-
17.10.23
17.10.23
-13.84%
22.12.22
22.12.22
Risky Investment
Schmitt Industries Inc.
Start price
Target price
Perf. (%)
€1.64
17.10.22
17.10.22
-
17.10.23
17.10.23
-99.97%
17.10.23
17.10.23
Probably not worthwhile Investment
Invitae Corp
Start price
Target price
Perf. (%)
€2.14
16.10.22
16.10.22
-
16.10.23
16.10.23
-3.57%
18.02.23
18.02.23
Risky Investment
Homology Medicines Inc
Start price
Target price
Perf. (%)
€1.31
16.10.22
16.10.22
-
16.10.23
16.10.23
-17.62%
27.12.22
27.12.22
Risky Investment
TCR2 Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.68
16.10.22
16.10.22
-
16.10.23
16.10.23
-6.83%
30.10.22
30.10.22
Could be very worthwhile Investment >20% year
Hypoport SE
Start price
Target price
Perf. (%)
€86.20
16.10.22
16.10.22
€90.00
16.10.23
16.10.23
-4.58%
17.10.22
17.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Standard Investments for future growth
Energiekontor
Start price
Target price
Perf. (%)
€87.50
15.10.22
15.10.22
€95.00
15.10.23
15.10.23
-17.49%
16.10.23
16.10.23
Could be worthwhile Investment >10% per year
CropEnergies AG
Start price
Target price
Perf. (%)
€14.22
15.10.22
15.10.22
€15.50
15.10.23
15.10.23
6.75%
25.10.22
25.10.22
Could be worthwhile Investment >10% per year
Delignit AG
Start price
Target price
Perf. (%)
€5.10
15.10.22
15.10.22
€7.00
15.10.23
15.10.23
-17.25%
16.10.23
16.10.23
Could be worthwhile Investment >10% per year
Applied DNA Sciences Inc.
Start price
Target price
Perf. (%)
€2.38
15.10.22
15.10.22
€1.00
15.10.23
15.10.23
-24.07%
29.10.22
29.10.22
Significant cyclical dependencies
Little known brand
Revenue decline/stagnation expected
ROE lower than 10% per year
Peloton Interactive Inc.
Start price
Target price
Perf. (%)
€7.52
15.10.22
15.10.22
€3.00
15.10.23
15.10.23
7.99%
29.10.22
29.10.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group